Small Caps Leverage Pricing Power Amidst Input Volatility
Smaller companies are successfully raising prices and subscription fees to offset rising costs and shifting consumer behavior.
Coverage: 10 of 784 companies in this theme (DUOL, CVCO, LTBR, RHI, DAVE, PGEN, RXST, NEU, ALGT, SGHT) — a sample, not the full set.
Pricing power is the defining signal for small caps this week, as companies across disparate sectors—from fintech to chemicals—are successfully hiking rates without triggering a collapse in demand. This ability to pass through costs is critical as input volatility persists, allowing these firms to maintain or expand margins even when volumes fluctuate.
In the digital economy, the shift toward higher monetization is stark. Dave (DAVE) tripled its new-member subscription price from $1 to $3 in mid-2025, yet this move did not materially reduce conversion or retention. The result was an 87% year-over-year increase in second-quarter 2026 subscription revenue. Similarly, Duolingo (DUOL) saw subscription bookings rise 10% to $250.3 million in the second quarter, driven by a combination of higher pricing and increased volume.
Industrial and chemical firms are using similar levers to combat supply-chain shocks. NewMarket (NEU) imposed petroleum-additives surcharges after Middle East disruptions drove up raw-material and operating costs. These surcharges increased gross and operating profit in the second quarter, even as shipment volumes fell 3.8% year over year. Cavco Industries (CVCO) also raised home prices, realizing 4.7% higher revenue per home. However, the victory was partial; higher input costs still dragged factory-built housing gross margins down 1.8 percentage points to 20.8%.
Demand patterns are diverging sharply within specialized medical sectors. Sight Sciences (SGHT) saw a massive surge in Interventional Dry Eye revenue, which grew 704% year over year to $2.7 million. This growth was fueled by an expansion of its customer base from 39 to 176 and higher average selling prices, which pushed gross margins to 80%. Precigen (PGEN) also saw a sequential doubling of PAPZIMEOS revenue to $53.1 million as adoption spread across community practices and major medical centers.
Conversely, RxSight (RXST) is struggling with a downturn in elective procedures. Product sales fell 19% year over year in the second quarter as weaker consumer sentiment pressured cataract-procedure demand. The company sold only 11 Light Delivery Devices compared to 40 in the prior-year period, and lens sales dropped by 2,463 units. This volume collapse, combined with higher-cost inventory, pushed product gross margins down to 71.2% from 74.9%.
Labor and capacity management are reflecting a cautious but evolving economy. Robert Half (RHI) reports that clients continue to hire cautiously, though interactions have steadily improved. The firm is seeing a specific shift in demand toward candidates who combine domain expertise with AI fluency. While contract-talent hours worked declined 2.8% year over year, average bill rates managed a 1.2% increase.
Travel and housing show a preference for high-value segments over broad volume. Allegiant Travel (ALGT) reduced standalone capacity by 6.8% in the second quarter but saw unit revenue jump 24.6%. By trimming off-peak service and preserving peak flying, the airline expanded its adjusted operating margin to 9.0% despite a 73% surge in fuel costs per gallon. Cavco Industries (CVCO) saw a similar split: sales through its own retail centers rose 34.7%, while sales to independent builders and developers fell 2.6%.